The story that caused all the trouble is finally broken, involving Dow, Starpharma and Dendritic Nanotechnologies as opposed to the Starpharma’s Dendritic Nanotechnologies unit leaked last week.
As usual, hype rears its ugly head as this now makes all three as Leading Developers of Nanotechnologies for the Pharmaceutical, Biotechnology Industries. Could that be leading developers as in we have a product or leading developers as in as were all scratching our heads, lets put them together and hope something falls out?